Safer Cordocentesis by New 25-Gauge Needles

Objective: The objective of this study was to establish safer cordocentesis by using newly produced 25-gauge needles rather than the needles currently used. Methods: Human umbilical cords were preserved in experiment 1. Pinching both ends, cordocenteses were performed by filling the cord with saline inside the sphere of the pressure-equilibrated Ringer’s solution bag in an aquarium. Pressure alterations were recorded before and after the cordocenteses (n = 5 in each needle) using 22-, 23-, and 25-gauge needles. In experiment 2, human umbilical blood after delivery was preserved. Umbilical blood was drawn in syringes, and fixed in syringe infusion pumps of 150 ml/h. The blood (n = 8) was then pushed into the test tubes through 22-, 23-, and 25-gauge needles. Hemolysis and platelet activation were evaluated. As in the case of clinical data, non-stress tests (NST) subsequent to cordocenteses were compared between 23-gauge (n = 19) and 25-gauge (n = 16) needles. Results: In experiment 1, the 25-gauge cordocenteses documented a more favorable pressure curve than other needles. In experiment 2, no statistical significance was observed for plasma-free hemoglobin, total bilirubin, hemoglobin, AST, LDH, potassium, platelet count, β-thromboglobulin, and platelet factor IV. As in the case of clinical data, NSTs subsequent to cordocenteses revealed strong significance in the duration to recover variability (p = 0.0003) and the duration to recover acceleration (p = 0.0033). Conclusion: We concluded that 25-gauge needles appear superior in avoiding blood loss in the leaking phase. Although blood drawing takes time in the sampling phase, no hemolysis or platelet activation was observed. NST proved that 25-gauge cordocenteses showed favorable patterns. We propose that use of 25-gauge needles is promising under appropriate procedures in cordocentesis.

[1]  Xinru Wang,et al.  Quantitative real‐time PCR technique for rapid prenatal diagnosis of Down syndrome , 2004, Prenatal diagnosis.

[2]  K. Furuya,et al.  Intrauterine therapy for a cytomegalovirus‐infected symptomatic fetus , 2004, BJOG : an international journal of obstetrics and gynaecology.

[3]  R. Smith-Bindman,et al.  Changes in the Utilization of Prenatal Diagnosis , 2004, Obstetrics and gynecology.

[4]  J. Philip,et al.  Late First-Trimester Invasive Prenatal Diagnosis: Results of an International Randomized Trial , 2004, Obstetrics and gynecology.

[5]  W. Martin,et al.  Middle cerebral artery Doppler velocimetric assessment in two cases of hydrops fetalis without fetal anaemia , 2004, Prenatal Diagnosis.

[6]  A. Liao,et al.  A comparison between middle cerebral artery peak systolic velocity and amniotic fluid optical density at 450 nm in the prediction of fetal anemia. , 2003, American journal of obstetrics and gynecology.

[7]  L. Dugoff,et al.  Invasive procedures to evaluate the fetus. , 2002, Clinical obstetrics and gynecology.

[8]  A. Pál,et al.  Fetomaternal Transfusion and Pregnancy Outcome after Cordocentesis , 2001, Fetal Diagnosis and Therapy.

[9]  M. Goldman.  Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia , 2000 .

[10]  M. Renlund,et al.  Thrombocytopenia in Term Infants: A Population‐Based Study , 2000, Obstetrics and gynecology.

[11]  L. A. Flore,et al.  Rapid confirmation of previously detected prenatal mosaicism by fluorescence in situ hybridization in interphase uncultured amniocytes. , 2000, Genetic testing.

[12]  Teramo,et al.  Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia , 1999, Transfusion medicine.

[13]  S. Hunter,et al.  Perinatal management of women with immune thrombocytopenic purpura: survey of United States perinatologists. , 1999, American journal of obstetrics and gynecology.

[14]  B. Petrikovsky.  Complications after cordocentesis appear excessive. , 1997, American Journal of Obstetrics and Gynecology.

[15]  T. Kelly,et al.  Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. , 1997, American journal of obstetrics and gynecology.

[16]  B. Petrikovsky,et al.  Cordocentesis using the combined technique; needle guide-assisted and free-hand. , 1997, Fetal Diagnosis and Therapy.

[17]  C. Weiner,et al.  Diagnostic fetal blood sampling-technique related losses. , 1996, Fetal Diagnosis and Therapy.

[18]  C. Lockwood,et al.  Complications of fetal blood sampling. , 1993, American journal of obstetrics and gynecology.

[19]  K. Wenstrom,et al.  Risk factors for cordocentesis and fetal intravascular transfusion. , 1991, American journal of obstetrics and gynecology.

[20]  F. Manning,et al.  Intrauterine transfusion--intraperitoneal versus intravascular approach: a case-control comparison. , 1990, American journal of obstetrics and gynecology.

[21]  F. Daffos,et al.  Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. , 1985, American journal of obstetrics and gynecology.